rs147993882

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_001280787.1(SURF1):​c.-117G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,614,056 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 1 hom. )

Consequence

SURF1
NM_001280787.1 5_prime_UTR_premature_start_codon_gain

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 2.51
Variant links:
Genes affected
SURF1 (HGNC:11474): (SURF1 cytochrome c oxidase assembly factor) This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22435895).
BP6
Variant 9-133354853-C-A is Benign according to our data. Variant chr9-133354853-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1083128.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SURF1NM_003172.4 linkuse as main transcriptc.211G>T p.Val71Leu missense_variant 3/9 ENST00000371974.8 NP_003163.1 Q15526-1E5KRX5
SURF1NM_001280787.1 linkuse as main transcriptc.-117G>T 5_prime_UTR_premature_start_codon_gain_variant 2/8 NP_001267716.1 Q15526A0A087WYS9
SURF1NM_001280787.1 linkuse as main transcriptc.-117G>T 5_prime_UTR_variant 2/8 NP_001267716.1 Q15526A0A087WYS9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SURF1ENST00000615505.4 linkuse as main transcriptc.-117G>T 5_prime_UTR_premature_start_codon_gain_variant 2/81 ENSP00000482067.1 A0A087WYS9
SURF1ENST00000371974.8 linkuse as main transcriptc.211G>T p.Val71Leu missense_variant 3/91 NM_003172.4 ENSP00000361042.3 Q15526-1
SURF1ENST00000615505.4 linkuse as main transcriptc.-117G>T 5_prime_UTR_variant 2/81 ENSP00000482067.1 A0A087WYS9
SURF1ENST00000437995.1 linkuse as main transcriptn.157G>T non_coding_transcript_exon_variant 2/85

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000756
AC:
19
AN:
251362
Hom.:
0
AF XY:
0.0000663
AC XY:
9
AN XY:
135836
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000233
AC:
34
AN:
1461714
Hom.:
1
Cov.:
32
AF XY:
0.0000248
AC XY:
18
AN XY:
727158
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000176
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000265
GnomAD4 genome
AF:
0.0000459
AC:
7
AN:
152342
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000144
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000529
ExAC
AF:
0.0000659
AC:
8
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 19, 2023Variant summary: SURF1 c.211G>T (p.Val71Leu) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7.6e-05 in 251362 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in SURF1 causing Leigh Syndrome (7.6e-05 vs 0.0018), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.211G>T in individuals affected with Leigh Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 01, 2022The c.211G>T (p.V71L) alteration is located in exon 3 (coding exon 3) of the SURF1 gene. This alteration results from a G to T substitution at nucleotide position 211, causing the valine (V) at amino acid position 71 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Leigh syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
20
DANN
Benign
0.90
DEOGEN2
Uncertain
0.67
D
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.54
FATHMM_MKL
Uncertain
0.88
D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Benign
1.3
L
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.28
Sift
Benign
0.22
T
Sift4G
Benign
0.19
T
Polyphen
0.020
B
Vest4
0.099
MutPred
0.71
Gain of loop (P = 0.069);
MVP
0.78
MPC
0.026
ClinPred
0.014
T
GERP RS
4.1
Varity_R
0.14
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147993882; hg19: chr9-136221708; API